Search Articles
SAN FRANCISCO – Impax Laboratories must face claims from shareholders that it ignored warnings from the Food and Drug Administration about deficient manufacturing conditions, among other issues, a federal judge ruled.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.